Xconomy’s Digital Events →
Stephen Friend is the co-founder and CEO of Sage Bionetworks.
Sponsored · Whitepaper
Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications
From Our Editors · Special Report
Becoming the Cell & Gene Therapy Hub
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates